Biotech Values

[mid_swe]

katie, I have been in and out in OXGN for several years but as a daytrader or for a maximum period of one month. Have been long since mid 2003.
This is what I found regarding the BMY agreement.

Despite the positive results, Bristol-Myers Squibb Co. ended its partnership with Oxigene on CA4P last week in a decision to focus on late-stage products, according to OxiGene.

http://finance.messages.yahoo.com/bbs?.mm=FN&board=7077146&tid=oxgn&sid=7077146&acti...

Note that cardiac toxicity has been discussed before, in July 2003 and back in 2002 and in October 2001.

I am in and out in MAXM. Know MAXM good but not as in depth as for OXGN.